Ligand Pharmaceuticals reported $352.94M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Amgen USD 26.73B 195M Jun/2025
Arrowhead Research USD 946.92M 188.3M Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Glaxosmithkline GBP 17.67B 676M Jun/2025
Insmed USD 2.08B 678.89M Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
Ligand Pharmaceuticals USD 352.94M 43.63M Jun/2025
MacroGenics USD 204.94M 12.55M Jun/2025
Merck USD 37.07B 1.56B Jun/2025
Pacira USD 745.61M 14.35M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Veracyte USD 414.68M 31.53M Jun/2025